Literature DB >> 8016013

Anti-neutrophil cytoplasmic antibody-associated paraneoplastic vasculitis.

J F Navarro1, C Quereda, M Rivera, F J Navarro, J Ortuño.   

Abstract

A 68 year old man presented with a systemic necrotizing vasculitis and elevated levels of anti-neutrophil cytoplasmic antibody (ANCA) which responded to treatment with steroids and cyclophosphamide, with a decrease in the titre of ANCA until its disappearance. Four months later he presented with weakness, loss of weight, aphonia and dysphagia. A computerized tomography scan showed a solid mass in the anterior mediastinum, and histological studies revealed an undifferentiated adenocarcinoma. Vasculitis improved although the malignancy progressed and ANCA was persistently negative. Our case demonstrates an association between ANCA and paraneoplastic vasculitis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8016013      PMCID: PMC2397594          DOI: 10.1136/pgmj.70.823.373

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  7 in total

1.  Vasculitis associated with non-Hodgkin's lymphoma.

Authors:  M Rivera; C González; A Gonzalo; C Quereda; L Fogué; J Ortuño
Journal:  Nephron       Date:  1993       Impact factor: 2.847

Review 2.  Vasculitis as a paraneoplastic syndrome. Report of 11 cases and review of the literature.

Authors:  J Sánchez-Guerrero; S Gutiérrez-Ureña; A Vidaller; E Reyes; A Iglesias; D Alarcón-Segovia
Journal:  J Rheumatol       Date:  1990-11       Impact factor: 4.666

Review 3.  Vasculitis associated with malignancy.

Authors:  L E Mertz; D L Conn
Journal:  Curr Opin Rheumatol       Date:  1992-02       Impact factor: 5.006

Review 4.  Vasculitis associated with malignancy. Experience with 13 patients and literature review.

Authors:  J M Greer; S Longley; N L Edwards; G J Elfenbein; R S Panush
Journal:  Medicine (Baltimore)       Date:  1988-07       Impact factor: 1.889

5.  Cutaneous granulomatous vasculitis: its relationship to systemic disease.

Authors:  L E Gibson; R K Winkelmann
Journal:  J Am Acad Dermatol       Date:  1986-03       Impact factor: 11.527

6.  Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis.

Authors:  J C Jennette; A S Wilkman; R J Falk
Journal:  Am J Pathol       Date:  1989-11       Impact factor: 4.307

7.  Paraneoplastic vasculitis. Unique syndrome of cutaneous angiitis and arthritis associated with myeloproliferative disorders.

Authors:  S Longley; J R Caldwell; R S Panush
Journal:  Am J Med       Date:  1986-06       Impact factor: 4.965

  7 in total
  5 in total

1.  Elevated serum levels of two anti-neutrophil cytoplasmic antibodies in a lung cancer patient: A case report.

Authors:  Shinichiro Okauchi; Tomohiro Tamura; Katsunori Kagohashi; Mio Kawaguchi; Hiroaki Satoh
Journal:  Biomed Rep       Date:  2016-09-06

2.  Anti-neutrophil cytoplasmic antibody and a pelvic mass.

Authors:  G L Jones; E J Kingdon; A P Burns
Journal:  J R Soc Med       Date:  2003-07       Impact factor: 18.000

3.  Beneficial Effect of Rituximab in the Treatment of Esophageal Cancer-Associated Pauci-Immune Glomerulonephritis.

Authors:  Heleen Ameye; Sabine Fransis; Evelyne Lerut; Christoph Metalidis; Ben Sprangers
Journal:  Kidney Int Rep       Date:  2016-06-29

4.  Simultaneous Occurrence of Sarcoidosis and Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis in a Patient with Lung Cancer.

Authors:  Kazuo Tsuchiya; Masato Karayama; Taichi Sato; Hideki Yasui; Hironao Hozumi; Yuzo Suzuki; Kazuki Furuhashi; Noriyuki Enomoto; Tomoyuki Fujisawa; Yutaro Nakamura; Naoki Inui; Haruhiko Sugimura; Hideo Yasuda; Takafumi Suda
Journal:  Intern Med       Date:  2019-07-22       Impact factor: 1.271

5.  Anti-Neutrophil Cytoplasmic Antibody-Associated Glomerulonephritis and Malignancy: A Case of a Patient Diagnosed with Renal Failure and Pulmonary Carcinoma Concurrently.

Authors:  Maki Asakura; Tetsu Akimoto; Ken Ohara; Takahiro Masuda; Yuko Ono; Osamu Saito; Daisuke Nagata
Journal:  Clin Med Insights Case Rep       Date:  2021-03-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.